These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28911145)

  • 1. Bone Mineral Density After Cessation of GH Treatment in Young Adults Born SGA: A 5-Year Longitudinal Study.
    Smeets CCJ; van der Steen M; Renes JS; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3508-3516. PubMed ID: 28911145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment.
    Goedegebuure WJ; van der Steen M; Kerkhof GF; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
    Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
    Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
    Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial.
    Renes JS; Willemsen RH; Mulder JC; Bakker-van Waarde WM; Rotteveel J; Oostdijk W; Houdijk EC; Westerlaken C; Noordam C; Verrijn Stuart AA; Odink RJ; de Ridder MA; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):854-61. PubMed ID: 25409576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular filtration rate, blood pressure and microalbuminuria in adults born SGA: A 5-year longitudinal study after cessation of GH treatment.
    Goedegebuure WJ; Kerkhof GF; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):892-898. PubMed ID: 31512772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ; Boonstra VH; Hokken-Koelega AC
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Kerkhof GF; Smeets CCJ; Hokken-Koelega ACS
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):975-985. PubMed ID: 29102566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA.
    Breukhoven PE; Kerkhof GF; van Dijk M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3710-6. PubMed ID: 21917862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Smeets CC; Kerkhof GF; Hokken-Koelega AC
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):106-116. PubMed ID: 28011067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
    Hokken-Koelega A; van Pareren Y; Arends N
    Horm Res; 2005; 64 Suppl 3():95-9. PubMed ID: 16439851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment.
    Willemsen RH; Willemsen SP; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3449-54. PubMed ID: 18559910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.